Rankings
▼
Calendar
VSTM Q2 2020 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena
VSTM
Verastem, Inc.
$376M
Q2 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$4M
+37.3% YoY
Gross Profit
$4M
81.8% margin
Operating Income
-$21M
-493.7% margin
Net Income
-$23M
-534.2% margin
EPS (Diluted)
$-1.67
QoQ Revenue Growth
-14.8%
Cash Flow
Operating Cash Flow
-$23M
Free Cash Flow
-$23M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$199M
Total Liabilities
$84M
Stockholders' Equity
$114M
Cash & Equivalents
$125M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4M
$3M
+37.3%
Gross Profit
$4M
$2M
+48.8%
Operating Income
-$21M
-$38M
+44.4%
Net Income
-$23M
-$42M
+45.5%
Revenue Segments
Product Revenue Reserves And Allowances Government Rebates And Other Incentives
$455,000
45%
Product Revenue And Allowances Returns
$326,000
32%
Product Revenue Reserves And Allowances Third Party Payer Chargebacks Discounts And Fees
$135,000
13%
Product Revenue Reserves And Allowances Trade Discounts And Allowances
$94,000
9%
← FY 2020
All Quarters
Q3 2020 →